Cargando…

Unmanipulated haploidentical transplantation for adult patients with hematological malignancies

Detalles Bibliográficos
Autores principales:	Ruggeri, Annalisa, Santoro, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Stem cell transplantation - Section 17
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925676/ https://www.ncbi.nlm.nih.gov/pubmed/35309805 http://dx.doi.org/10.1097/HS9.0000000000000247

Ejemplares similares

Medical management of acute responses to radiation
por: Chao, Nelson J., et al.
Publicado: (2019)

Microbiota and Graft-versus Host disease: a double-edged sword
por: Holler, Ernst, et al.
Publicado: (2019)

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
por: Santoro, Nicole, et al.
Publicado: (2017)

Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies
por: Gao, Xiao-Ning, et al.
Publicado: (2018)

Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT
por: Piemontese, Simona, et al.
Publicado: (2019)

Stem cell transplantation
por: Schaap, Nicolaas
Publicado: (2019)

Granulocyte Colony-Stimulating Factor-Primed Unmanipulated Haploidentical Blood and Marrow Transplantation
por: Chang, Ying-Jun, et al.
Publicado: (2019)

Innovative Platforms for Haploidentical Stem Cell Transplantation: The Role of Unmanipulated Donor Graft
por: Ciceri, Fabio, et al.
Publicado: (2011)

Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning
por: Wagner, John E., et al.
Publicado: (2021)

Selected memory T cells infused post–haploidentical hematopoietic stem cell transplantation persist and hyperexpand
por: van Beek, Jasper J. P., et al.
Publicado: (2022)

Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Peripheral Blood or Bone Marrow—Review of Published Literature
por: Farhan, Shatha, et al.
Publicado: (2016)

Haploidentical haematopoietic stem cell transplantation for thalassaemia major based on an FBCA conditioning regimen
por: Sun, Qixin, et al.
Publicado: (2018)

PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation
por: Al-Homsi, A. Samer, et al.
Publicado: (2023)

Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation
por: Petersdorf, Effie W., et al.
Publicado: (2023)

Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse
por: Shapiro, Roman M., et al.
Publicado: (2023)

Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT
por: Santoro, Nicole, et al.
Publicado: (2018)

Early Report on COVID-19 Infections in Pediatric Heart Transplant Recipients and Candidates
por: Conway, J., et al.
Publicado: (2021)

Impact of allele-level HLA matching on outcomes after double cord blood transplantation in adults with malignancies
por: Fatobene, Giancarlo, et al.
Publicado: (2023)

A critical assessment of dose effects of post‐thaw CD34 on autologous stem cell transplantation treatment of haematological malignancies
por: Duarte, Gustavo de Carvalho, et al.
Publicado: (2023)

A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia
por: Piemontese, Simona, et al.
Publicado: (2017)

A systematic literature review of the clinical signs and symptoms of veno‐occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation in adults and children
por: Angus, James, et al.
Publicado: (2022)

Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies
por: Fabricius, William A., et al.
Publicado: (2016)

Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (GVHD) in the absence of GVHD prophylaxis
por: Roy, Denis Claude, et al.
Publicado: (2019)

Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type
por: Mehta, Rohtesh S., et al.
Publicado: (2023)

Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donors
por: Bashey, Asad, et al.
Publicado: (2023)

COVID‐19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta‐analysis
por: Lim, Yeong Jer, et al.
Publicado: (2022)

SALIVA VERSUS SECREÇÃO ORO-NASOFARÍNGEA PARA A DETECÇÃO MOLECULAR DE SARS-COV-2 E SUA CORRELAÇÃO COM O STATUS CLÍNICO E VACINAL
por: Furtado, Fabiana Barcelos, et al.
Publicado: (2022)

Interest of the preventive and curative use of defibrotide on the occurrence and severity of sinusoidal obstruction syndrome after hematopoietic stem cell transplant in children
por: Rudebeck, Carl J., et al.
Publicado: (2022)

Global longitudinal strain is superior to ejection fraction for long‐term follow‐up after allogeneic hematopoietic stem cell transplantation
por: Watanabe, Marika, et al.
Publicado: (2022)

Early diagnosis of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation, with modified diagnostic criteria including refractory thrombocytopenia
por: Ichikawa, Hiroya, et al.
Publicado: (2023)

The 17‐gene stemness score associates with relapse risk and long‐term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia
por: Kim, Dennis D. H., et al.
Publicado: (2022)

Early relapse prediction after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage‐specific chimerism analysis
por: Lindahl, Hannes, et al.
Publicado: (2022)

Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia
por: Dou, Li-Ping, et al.
Publicado: (2018)

Persistent Facial and Chest Papular and Pustular Eruption in a Stem Cell Transplant Patient
por: Keiser, Monika F., et al.
Publicado: (2021)

Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis: a Review of Current Literature and Future Directions for Transplant Haematologists and Oncologists
por: Das, Joyutpal, et al.
Publicado: (2019)

Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study
por: Malagola, Michele, et al.
Publicado: (2023)

Impact of the Affordable Care Act on Stem Cell Transplantation
por: Farnia, Stephanie, et al.
Publicado: (2014)

Nonengraftment Haploidentical Cellular Therapy for Hematologic Malignancies
por: Reagan, John L., et al.
Publicado: (2012)

Rapid Recovery of CD3(+)CD8(+) T Cells on Day 90 Predicts Superior Survival after Unmanipulated Haploidentical Blood and Marrow Transplantation
por: Tian, Deng-Mei, et al.
Publicado: (2016)

CD94 Ex Vivo Cultures in a Bone Marrow Transplantation Setting
por: Abrams, Kraig, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f614ooa5ueio3ldhqiaa6hcke8